Sunday, July 28, 2024
August 25 - 28, 2023; Amsterdam, The Netherlands and Online
Register here to get unlimited access to Medscape's conference coverage, medical news, CME and point-of-care tools.
ESC 2023
Optimal Antiplatelet Regimen in "Bi-Risk" ACS?
ESC 2023
SGLT2i Tied to Fewer Post-MI Deaths in T2D
ESC 2023
Longer Edoxaban May Benefit Cancer Patients With Distal DVT
ESC 2023
Echocardiography Boosts Prognostic Power in T1D
ESC 2023
Muvalaplin and Olpasiran Show Promise in Lowering Lp(a)
ESC 2023
STEMI Trial Fails to Support Post-PCI Anticoagulation
ESC 2023
SGLT2 Inhibitors: No Benefit in Hospitalized COVID-19
Parity for OCT, IVUS in Intravascular Imaging-Guided PCI
ESC 2023
Should Intravascular Imaging Be Almost Routine in PCI?
ESC 2023
Recent Leaps in HF Therapy Spur ESC Guideline-Focused Update
ESC 2023
VKA Therapy Beats Switch to NOAC in Frail AF Patients
ESC 2023
New ESC ACS Guideline Combines STEMI and NSTE-ACS
ESC 2023
Anti-inflammatory Strategy in Acute Myocarditis — No Benefit
ESC 2023
SGLT2i Safety in Acute Heart Failure Confirmed by New Data
ESC 2023
Aspirin Still Needed in First Month After PCI: STOPDAPT-3
ESC 2023
ESC Issues First Comprehensive Cardiomyopathy Guidelines
ESC 2023
Minimizing Atrial Pacing No Benefit in Sinus Node Disease
ESC 2023
Impact of RV Pacing in HF, CRT Benefit Shown in BUDAPEST-CRT
ESC 2023
Screening Finds High Rates of CVD in Diabetes, COPD Patients
ESC 2023
Parity for Prompt vs Staged STEMI Complete Revascularization
ESC 2023
Dietary Nitrates Reduce Contrast-Induced Nephropathy in ACS
ESC 2023
More Weight Loss Linked With More Benefit in STEP-HFpEF
ESC 2023
Advanced HF No Obstacle to AF Ablation Success: CASTLE-HTx
ESC 2023
Cardiac Arrest Centers No Benefit in OHCA Without STEMI
ESC 2023
Pulsed Field Ablation Challenges Conventional Devices in AF
ESC 2023
Acoramidis Shows Encouraging Results in ATTR Cardiomyopathy
ESC 2023
ECMO for Shock in Acute MI Won't Help, May Harm: ECLS-SHOCK
ESC 2023
New ESC Guidelines for Infective Endocarditis
ESC 2023
No Reduction in AF After Noncardiac Surgery With Colchicine: COP-AF
ESC 2023
ESC Backs SGLT2i Plus GLP-1 in Diabetes with High CVD Risk
ESC 2023
Traditional Chinese Medicine Improves Outcomes in HFrEF
ESC 2023
FIRE a Win in MI Physiology-Based Complete Revascularization
ESC 2023
IV Iron Shows Only Modest Benefit in HF: HEART-FID
ESC 2023
Anticoagulation No Benefit in Presumed AF on Cardiac Devices
ESC 2023
Wegovy Scores HFpEF Benefits in People With Obesity
Amsterdam Hosts ESC 2023 After Yielding to COVID in 2020
© WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Quick, Reliable Marker to PUSH Decongestive Therapy in AHF
Pulsed-Field Ablation for AF: The Promise and the Reality
Don't Fear POTS: Tips for Diagnosis and Treatment
Don't Assume Newer Is Better for All -- Randomize: FRAIL-AF
Beyond A1c: Implementing the New ESC 2023 Guidelines
SGLT2i in Acute Heart Failure, The Earlier The Better?
Diabetes and Heart Disease Highlights From ESC 2023
SCD in Athletes: Lessons From High-Profile Cases
Obesity and Nutrition Highlights From ESC 2023
Intravascular Imaging in PCI: Time for a Guideline Update?
Heart Failure Guidelines Update: What the ESC Got Right
Is AF Ablation the Fifth Pillar in Heart Failure Care?
Is Complete Revascularization Now Compulsory?
The Most Important Study From ESC
AF Ablation in End-Stage HF: Too Good to Be True?
Pulsed Field Ablation for AF Underwhelming in ADVENT
Semaglutide's Big STEP in HFpEF With Obesity
Supporting Evidence for a Common Practice
Semaglutide in HFpEF Cleared a Low Bar
How Much AF Warrants Anticoagulation?
Mandrola's 5 Things to Look for at the Upcoming ESC 2023
